Home
Scholarly Works
Potential Mortality Reduction with Optimal Usage...
Conference

Potential Mortality Reduction with Optimal Usage of sacubitril/valsartan Therapy for the Treatment of Heart Failure in Canada

Authors

McKelvie R; White M; Vaillancourt M; Haddad P; Zaour N

Volume

135

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

March 7, 2017

Name of conference

Scientific Sessions of the American-Heart-Association on Epidemiology and Prevention/Lifestyle and Cardiometabolic Health

Conference place

Portland, OR

Conference start date

March 7, 2017

Conference end date

March 10, 2017

Conference proceedings

CIRCULATION

ISSN

0009-7322

Contact the Experts team